A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, ACTIVE-CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF COMBINATION OF SOLIFENACIN SUCCINATE WITH MIRABEGRON COMPARED TO SOLIFENACIN SUCCINATE AND MIRABEGRON MONOTHERAPY IN SUBJECTS WITH OVERACTIVE BLADDER

Registry ID

178-CL-102

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

ASTELLAS PHARMA EUROPE B.V.

Start date

2014-04-23

Last update

2013-09-05

Conditions

• OVERACTIVE BLADDER

Related clinical trials

• AN INTERNATIONAL PHASE 3, RANDOMIZED, DOUBLE-BLIND, ACTIVE (TOLTERODINE)-CONTROLLED MULTICENTER EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF VIBEGRON IN PATIENTS WITH SYMPTOMS OF OVERACTIVE BLADDER
• EFFICACITÉ ET TOLÉRABILITÉ DE LA FÉSOTÉRODINE CHEZ LES ENFANTS ATTEINTS DE VESSIE HYPERACTIVE: PHASE D¿EXTENSION.
• EFFICIENCY AND TOLERANCE OF FESOTERODIN AND OXYBUTYNIN IN CHILDREN WITH A HYPERACTIVE BLADDER: A COMPARATIVE STUDY

View on source registry